PT  - JOURNAL ARTICLE
AU  - Nicholas E Clifton
AU  - Elliott Rees
AU  - Peter A Holmans
AU  - Antonio F. Pardiñas
AU  - Janet C Harwood
AU  - Arianna Di Florio
AU  - George Kirov
AU  - James TR Walters
AU  - Michael C O’Donovan
AU  - Michael J Owen
AU  - Jeremy Hall
AU  - Andrew J Pocklington
TI  - Genetic association of FMRP targets with psychiatric disorders
AID  - 10.1101/2020.02.21.952226
DP  - 2020 Jan 01
TA  - bioRxiv
PG  - 2020.02.21.952226
4099  - http://biorxiv.org/content/early/2020/02/25/2020.02.21.952226.short
4100  - http://biorxiv.org/content/early/2020/02/25/2020.02.21.952226.full
AB  - Genes encoding the mRNA targets of Fragile X mental retardation protein (FMRP) are enriched for genetic association with psychiatric disorders. However, many FMRP targets possess functions that are themselves genetically associated with psychiatric disorders, including synaptic transmission and plasticity, making it unclear whether the genetic risk is truly related to binding by FMRP or is alternatively mediated by the sampling of genes better characterised by another trait or functional annotation. Using published common variant, rare coding variant and copy number variant data, we examined the relationship between FMRP binding and genetic association with schizophrenia, major depressive disorder and bipolar disorder. We then explored the partitioning of genetic association between overrepresented functional categories. High-confidence targets of FMRP were enriched for common schizophrenia risk alleles, as well as rare loss-of-function and de novo nonsynonymous variants in cases. Similarly, through common variation, FMRP targets were associated with major depressive disorder, and we present novel evidence of association with bipolar disorder. These relationships could not be explained by membership of other functional annotations known to be associated with psychiatric disorders, including those related to synaptic structure and function. This study reinforces the evidence that targeting by FMRP captures a subpopulation of genes enriched for genetic association with a range of psychiatric disorders, across traditional diagnostic boundaries.FMRPFragile X mental retardation proteinmRNAMessenger ribonucleic acidMAGMAMulti-marker Analysis of GenoMic AnnotationGWASGenome-wide association studyDNADeoxyribonucleic acidCNVCopy number variantGOGene ontologyMGIMouse genome informaticsMPMammalian phenotypeCYFIP1Cytoplasmic FMR1 interacting protein 1PGCPsychiatric genomics consortium